日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Resolving cognitive heterogeneity in white matter hyperintensities through integrated analyses of microbiome, metabolome, and brain glymphatic function

通过整合微生物组、代谢组和脑淋巴系统功能分析,解析白质高信号中的认知异质性

Xu, Xiaotao; Zhou, Xia; Zhang, Mengwei; Fang, Jingjing; Yan, Zhiqing; Zhu, Xiaoqun; Yu, Yongqiang; Zhu, Jiajia

Inetetamab plus camrelizumab and utidelone for pretreated HER2-positive advanced breast cancer: a prospective, single-arm, phase 2 study

伊奈妥单抗联合卡瑞利珠单抗和乌替德隆治疗既往接受过治疗的HER2阳性晚期乳腺癌:一项前瞻性、单臂、II期研究

Lv, Huimin; Sun, Tao; Ling, Xiaoling; Liu, Xinlan; Yang, Jin; Zhang, Mengwei; Niu, Limin; Chen, Shumin; Liu, Zhenzhen; Wang, Chengzheng; Sun, Huihui; Wang, Jing; Zeng, Huiai; Zhao, Shengnan; Guo, Lanwei; Feng, Yajing; Zhang, Zhiqing; Xia, Qingxin; Qiu, Rongguo; Yan, Min

3D body shape-based phenotyping for precision risk stratification of metabolic syndrome

基于三维体型的表型分析用于代谢综合征的精准风险分层

Ran, Zhujie; Hu, Yaoda; He, Huijing; Han, Wei; Chen, Xingming; Tu, Ji; Li, Ang; Lin, Binbin; Liu, Qihang; Lu, Zhiming; Wang, Qing; Huang, Haibo; Wang, Weihao; Xu, Da; Wang, Zichao; Chen, Zhili; Zhang, MengWei; Shan, Guangliang

A retrospective cohort study on the association between RAR and mortality in peritoneal Dialysis patients

一项关于腹膜透析患者RAR与死亡率之间关联的回顾性队列研究

Zhang, Mengwei; Ren, Zhouhao; Zhang, Shunshun; Lü, Yurui; Fu, Ruting; Gong, Shuwen; Shen, Shuijuan

CT-based radiomics and intratumoral heterogeneity for predicting benign and malignant lesions in solid pulmonary nodules

基于CT的放射组学和肿瘤内异质性预测肺实性结节的良恶性病变

Lv, Yurui; Zhang, Mengwei; Song, Yining; Huang, Yanan; Mao, Haijia; Shen, Lingyan; You, Yi; Yu, Jinna; Xie, Dong; Zhao, Li

Efficacy and safety of TAS-102 plus Surufatinib in third and later line metastatic pancreatic cancer: a prospective, single center and biomarker exploratory, phase II study

TAS-102联合苏鲁替尼治疗三线及后续转移性胰腺癌的疗效和安全性:一项前瞻性、单中心、生物标志物探索性II期研究

Lu, Yunxin; Lin, Qingguang; Mo, Yongxin; Liu, Furong; Zhang, Mengwei; Huang, Runjie; Wang, Yun; Wang, Yinnan; Wang, Zhiqiang; Luo, Huiyan; Guo, Guifang; Chen, Jianwen; Liu, Yu; He, Mingming; Wang, Fenghua; Wang, Feng; Zhang, Dongsheng

Utidelone Plus Bevacizumab for ERBB2-Negative Metastatic Breast Cancer and Active Brain Metastases: The U-BOMB Phase 2 Nonrandomized Clinical Trial

乌替隆联合贝伐单抗治疗ERBB2阴性转移性乳腺癌和活动性脑转移:U-BOMB II期非随机临床试验

Yan, Min; Lv, Huimin; Liu, Xinlan; Wang, Shusen; Geng, Cuizhi; Song, Yuhua; Liu, Zhenzhen; Niu, Limin; Zhang, Mengwei; Wang, Chengzheng; Feng, Yajing; Zeng, Huiai; Sun, Huihui; Wang, Jing; Xiang, Yufen; Tang, Li; Qiu, Rongguo

The role of parkin in monkey

帕金蛋白在猴子中的作用

Zhang, Shuyan; Zhang, Mengwei; Xu, Shimeng; Fu, Xiaochuan; Liao, Qiumin; Pan, Bin; Cui, Liujuan; Liu, Pingsheng; Song, Pingping; Krainc, Dimitri

Global, regional, and national burden of esophageal cancer: a systematic analysis of the Global Burden of Disease Study 2021

全球、区域和国家食管癌负担:2021年全球疾病负担研究的系统分析

Jin, Weiqiu; Huang, Kaichen; Ding, Ziyin; Zhang, Mengwei; Li, Chongwu; Yuan, Zheng; Ma, Ke; Ye, Xiaodan

Global cancer burdens related to human behaviors in 1990-2044: a population-based cross-sectional and forecast study

1990-2044年与人类行为相关的全球癌症负担:一项基于人群的横断面和预测研究

Jin, Weiqiu; Huang, Kaichen; Zhang, Mengwei; Jiang, Longlin; Huang, Yanruo; Wang, Han; Tian, Yu; Zhu, Hongda; Zou, Ningyuan; Pan, Hanbo; Xuzhang, Wendi; Jiang, Long; Huang, Jia; Luo, Qingquan; Ye, Xiaodan; Yuan, Zheng